Abstract
We hypothesized that the function of both sinusoidal and canalicular transporters importantly controls the concentrations of organic anions within normal hepatocytes. Consequently, we investigated how acute transport regulation of the sinusoidal organic anion transporting polypeptides (Oatps) and the canalicular multidrug resistance associated protein 2 (Mrp2) determines the hepatic concentrations of the organic anion gadolinium benzyloxypropionictetraacetate (BOPTA) in rat livers. Livers were perfused with labeled BOPTA in different experimental settings that modify the function of Oatps and Mrp2 through the protein kinase C (PKC) pathway. Intrahepatic concentrations were continuously measured with a gamma probe placed above rat livers. Labeled BOPTA was also measured in perfusate and bile. We showed that when the function of Oatps and Mrp2 is modified in such a way that BOPTA entry and exit are similarly decreased, concentrations of organic anions within hepatocytes remain unaltered. When exit through Mrp2 is abolished, hepatic concentrations are high if entry through Oatps is only slightly decreased (livers without Mrp2 expression) or low if BOPTA uptake is more importantly decreased (livers perfused with a PKC activator). These results highlight that the function of both sinusoidal and canalicular transporters is important to determine the concentration of organic anions within hepatocytes.
Footnotes
-
This work was supported by Fonds National Suisse de la Recherche Scientifique grants 3200-100868 and 3200-109977 (to C.M.P.).
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
-
doi:10.1124/mol.106.030759.
-
ABBREVIATIONS: OATP, organic anion transporting polypeptide; MRI, magnetic resonance imaging; BOPTA, gadolinium benzyloxypropionictetraacetate; KHB, Krebs-Henseleit-bicarbonate; ZO, zona occludens; HRP, horseradish peroxidase; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; E3S, estrone-3-sulfate; DTPA, gadolinium diethylenetriaminepentaacetic acid; ANOVA, analysis of variance; Gö6976, 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole; BSP, bromosulfophthalein; VP, vasopressin.
- Received September 18, 2006.
- Accepted January 16, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|